No Data
No Data
Major Investment Boosts Confidence in Oruka Therapeutics!
Insider Purchase: 10% Owner at $ORKA Buys 88,794 Shares
Oruka Therapeutics Sees $1.41 Million in Stock Purchases by Venrock
Oruka Therapeutics to Present at Multiple March Investor Conferences
Stifel Maintains Oruka Therapeutics(ORKA.US) With Buy Rating, Maintains Target Price $49
This Expand Energy Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Tuesday